Josephine Forbes
Mater Research Institute - The University of Queensland, QLD, Australia
- This delegate is presenting an abstract at this event.

Professor Josephine Forbes is a global leader driving innovative therapies for diabetic kidney disease. She fosters her pioneering bench research all the way to clinical studies. Her accolades include the Commonwealth Health Minister’s Award for Outstanding contribution to Medical Research. Despite having only conferred her PhD in yr2000, she already has over 150 publications with ~10000 citations, >$6 million in research funding, patents and commercial partners. She is consistently invited to lecture nationally and internationally and as a member of global and national scientific committees. Her peak body leadership roles including the Australian Diabetes Society and Diabetes Australia Research Trust ensure strong advocacy for health research/ers and consumers.
Presentations this author is a contributor to:
Endogenous IL-22 is an Intrinsic Suppressor of β-cell ER Stress and Islet Inflammation and Exogenous IL-22 Restores Glycaemic Control in Obesity (#39)
5:05 PM
Michael McGuckin
IMMUNE – BETA CELL INTERACTIONS II
Analysis of immune, metabolic and clinical biomarkers implicates inflammatory and stress pathways in the pre-clinical development of type 1 diabetes (#155)
6:00 PM
Mark Harris
POSTER SESSION 2 / DRINKS
Analysis of immune, metabolic and clinical biomarkers implicates inflammatory and stress pathways in the pre-clinical development of type 1 diabetes (#44)
11:15 AM
Ranjeny Thomas
ANTIGENS AND BIOMARKERS II